Search
Candel Therapeutics Inc
CADLAdd to Watchlist
9.560USD
-0.300-3.04%
Close 07-24 16:00（ET）Quotes delayed by 15 min
524.83MMarket Cap
LossP/E TTM
Candel Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-24The current valuation score of Candel Therapeutics Inc is 7.29, ranking 250 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is -9.47, which is -93.55% below the recent high of -0.61 and -30.90% above the recent low of -12.40.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.